Clinical Trials
2 trialsNCT00006267 2013-07-09
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Withdrawn
NCT00006230 2012-09-24
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed